Skip to content
10-Q

Quarterly Report

BIOADAPTIVES, INC. BDPT

0001640334-26-000911

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 12.01M sh
Shares Diluted Q1 2026 · Mar 31, 2026 12.01M sh
Shares Diluted Q1 2026 · Mar 31, 2025 9.05M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$84.84K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$97.91K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$2.14M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$2.13M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$1.57M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$1.46M
Current Liabilities Q1 2026 · Mar 31, 2026 $2.27M
Current Liabilities Q1 2026 · Dec 31, 2025 $2.36M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.27M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.36M
Current Assets Q1 2026 · Mar 31, 2026 $123.45K
Current Assets Q1 2026 · Dec 31, 2025 $211.9K
Total Assets Q1 2026 · Mar 31, 2026 $135.95K
Total Assets Q1 2026 · Dec 31, 2025 $225.9K
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.01
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.02
Sga Expense Q1 2026 · Mar 31, 2026 $181.05K
Sga Expense Q1 2026 · Mar 31, 2025 $143.38K
Net Income Q1 2026 · Mar 31, 2026 −$111.09K
Net Income Q1 2026 · Mar 31, 2025 −$197.14K
Operating Income Q1 2026 · Mar 31, 2026 −$198.22K
Operating Income Q1 2026 · Mar 31, 2025 −$249.15K
Gross Profit Q1 2026 · Mar 31, 2026 $4.11K
Gross Profit Q1 2026 · Mar 31, 2025 $0
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.4K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $0
Revenue Q1 2026 · Mar 31, 2026 $5.51K
Revenue Q1 2026 · Mar 31, 2025 $0